Susquehanna International Group, LLP Soligenix, Inc. Transaction History

Susquehanna International Group, LLP

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 14, 2023	SELL	$0.4 - $168.0 $2,744 - $1.15 Million	-6,862 Reduced 32.84%	14,034 $6,000
Q3 2022 Nov 14, 2022	SELL	$0.51 - $117.79 $996 - $230,043	-1,953 Reduced 8.55%	20,896 $9,000
Q2 2022 Aug 15, 2022	BUY	$0.4 - $0.75 $9,139 - $17,136	22,849 New	22,849 $14,000
Q1 2022 May 16, 2022	SELL	$0.61 - $0.75 $6,154 - $7,567	-10,090 Closed	0 $0
Q4 2021 Feb 14, 2022	BUY	$0.66 - $1.1 $6,659 - $11,099	10,090 New	10,090 $7,000
Q3 2019 Nov 14, 2019	SELL	$0.72 - $1.31 $11,088 - $20,175	-15,401 Closed	0 $0
Q2 2019 Aug 14, 2019	SELL	$0.67 - $0.91 $16,183 - $21,980	-24,154 Reduced 61.06%	15,401 $11,000
Q1 2019 May 15, 2019	SELL	$0.88 - $1.04 $56,133 - $66,339	-63,788 Reduced 61.72%	39,555 $36,000
Q4 2018 Feb 14, 2019	BUY	$0.85 - $2.1 $87,841 - $217,020	103,343 New	103,343 $89,000

Ticker SNGX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 43,105,200
Market Cap $125M
Description
Soligenix, Inc., a late-stage biopharmaceutical company, focuses on developing and commercializing products to treat rare diseases in the United States. It operates in two segments, Specialized BioTherapeutics and Public Health Solutions. The Specialized BioTherapeutics segment develops SGX301 (HyBryte), a novel photodynamic therapy, which has c...

Get notified when there are updates to the investment portfolio of Susquehanna International Group, LLP, based on Form 13F filings with the SEC.

Stay updated on Susquehanna International Group, LLP with notifications on news.